QS-21 adjuvant
Drug timelines are a Plus or Pro feature.
6 regulatory and trial events tracked for QS-21 adjuvant, covering 2012-01-31 to 2025-08-05. Get the full timeline:
Most recent: Clinical Trial Update: The TG01 Study With TG01/QS-21 Vaccine in Patients With High-risk Smouldering Multiple Myeloma and Multiple Myeloma [Phase 1, Phase 2]